As of Aug 26
| +0.04 / +1.49%|
The 1 analysts offering 12-month price forecasts for OHR Pharmaceutical Inc have a median target of 13.00, with a high estimate of 13.00 and a low estimate of 13.00. The median estimate represents a +376.19% increase from the last price of 2.73.
The current consensus among 2 polled investment analysts is to Buy stock in OHR Pharmaceutical Inc. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.